Article Text

Download PDFPDF
Autism spectrum disorders: clinical and research frontiers
  1. E B Caronna1,
  2. J M Milunsky2,
  3. H Tager-Flusberg3
  1. 1
    Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA
  2. 2
    Departments of Pediatrics & Genetics and Genomics, Center for Human Genetics, Boston University School of Medicine, Boston, MA, USA
  3. 3
    Department of Anatomy and Neurobiology & Pediatrics, Boston University School of Medicine, Boston, MA, USA
  1. Dr Elizabeth B Caronna, Division of Developmental and Behavioral Pediatrics, Boston Medical Center, 88 East Newton St, Vose Hall 4, Boston, MA 02118, USA; Elizabeth.Caronna{at}bmc.org

Abstract

Autism spectrum disorders (ASD) are common neurodevelopmental disorders that occur along a broad continuum of severity with impairments in social interactions, communication and behaviour. This review highlights recent advances in autism research that shed light on the causes of the disorder and that have implications for clinical practice. It focuses on (1) the rising prevalence of ASD with attention given to recent epidemiological studies, (2) important genetic discoveries that may affect clinical evaluation of children with ASD, (3) active areas of research in cognitive neuroscience that seek to explain the underlying mechanisms of a complex disorder and (4) important studies on clinical populations with implications for screening and early identification of infants and toddlers with ASD.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: This work was funded through grants from the Maternal and Child Health Bureau (T77MC00016; EBC), the Irving B Harris Foundation (EBC), the Autism Consortium (EBC and JMM), the National Institutes of Health (U19DC03610, U54MH66398, R21DC08637; HT-F) and Autism Speaks (HT-F).

  • Competing interests: None.

Linked Articles

  • Atoms
    Howard Bauchner